A federal district court ruled in favor of the Health Resources and Services Administration, but raised questions about ...

A district court ruled that the HHS does have the power to review drug manufacturers’ plans to pay hospitals rebates instead ...

Hospital groups are celebrating a federal judge’s initial ruling against pharmaceutical makers who contended a government ...

Hearings were originally scheduled for this week on SB 2385 and HB 3350, which would stop drugmakers from cutting off steep ...

The House and Senate passed HB 2048, the 340B Nondiscrimination Act. The bill would lock in and expand Obamacare Medicaid ...

A federal judge partly sided with HHS over its decision to not approve proposals from Bristol Myers Squibb Co., Novartis AG, ...

The bill would bolster a federal drug program in Oklahoma, even though conservative critics have warned it is a backdoor ...

A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must ...

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we ...

In the final month of Connecticut’s state legislative session lawmakers face a number of critical decisions, but none more important than those that affect the health care of every single person in ...

Health care costs continue to rise, forcing LGBTQ+ business owners and patients across New York to pay more for coverage and ...

B was established to address healthcare disparities by providing discounted medications to low-income and underserved ...